Tim Lowinger

Company: Mersana Therapeutics

Job title: Chief Scientific & Technology Officer

Seminars:

Understanding the Clinical Efficacy of Immune Stimulating Conjugates 4:45 pm

Examining Upifitamab Rilsodotin clinical data Showcasing results from the UP-NEXT, Phase III monotherapy trial in platinum sensitive recurrent ovarian cancer Exploring results from XMT-1592 and XMT-1660 dose escalation trial resultsRead more

day: day 1- pm

Industry Leaders’ Panel Discussion 8:30 am

Outlining the most exciting developments within the last 12 months Exploring what the current clinical and commercialization landscape looks like Sharing the biggest up and coming trends within the ADC field Examining the next big challenges ADC developers will faceRead more

day: day 1- am